MedPath

Dual-targeting HER2 and PD-L1 CAR-T cells

Generic Name
Dual-targeting HER2 and PD-L1 CAR-T cells

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Early Phase 1
Recruiting
Posted: 2020/12/24
Sponsor:
Sichuan University

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath